13F Filings/Biggest Stakes

Biggest stakes

The largest stakes by share of the company owned — a manager’s reported shares as a percentage of shares outstanding. Unlike conviction (% of the fund’s portfolio), this surfaces who owns the most of a company, often concentrated, activist-style positions.

↗
1,500 results
1
CYCLERION THERAPEUTICS INCCYCN
47.5% · $1M
2
47.2% · $207K
4
GOSSAMER BIO INCGOSS
41.8% · $421K
5
INTERNATIONAL TOWER HILL MINTHM
39.9% · $208M
6
39.8% · $5M
7
CVR Partners, LPUAN
39.4% · $464M
8
39.3% · $395K
9
39.2% · $108M
10
GREENLAND MINES LTDGRML
38.7% · $1M
11
37.0% · $3.7B
12
36.5% · $3M
13
36.3% · $2M
14
Skye Bioscience, Inc.SKYE
35.6% · $1M
15
35.0% · $79M
16
GOSSAMER BIO INCGOSS
34.6% · $338K
17
Kodiak Sciences Inc.KOD
31.7% · $776M
18
31.6% · $1.2B
19
CORE LABORATORIES INCCLB
30.7% · $164M
20
FRACTYL HEALTH INCGUTS
30.0% · $3M
1–20 of 1,500
1 / 75

Reported shares ÷ shares outstanding, shown between 0.5% and 60% to exclude noise. Coverage grows as shares-outstanding data refreshes.

About this ranking

What does "% of company owned" mean?

A manager’s reported shares divided by the company’s total shares outstanding — how much of the whole company that fund holds, independent of the fund’s own size.

Why is this different from "highest conviction"?

Conviction measures a position as a share of the fund’s portfolio; this measures it as a share of the company. A big stake skews toward smaller companies (it’s far easier to own 5% of a small-cap than of a mega-cap).

How is it calculated?

Reported 13F shares ÷ shares outstanding (from EODHD fundamentals), shown between 0.5% and 60% to exclude noise and data artifacts. Long U.S.-listed equity only.